ADC Therapeutics secures $100 million in a Private Equity deal to extend its cash runway into 2028, aiming to support clinical development and commercialization activities.
Amount Raised
$100 Million
Round Type
Private Equity
LausanneBiotechnologyHealth CareTherapeuticsDescription
ADC Therapeutics announces a $100 million PIPE financing to sell equity securities to institutional investors. The funds will primarily support the clinical development and commercialization of ZYNLONTA. The transaction is expected to close on June 16, 2025. Additionally, the company plans workforce reductions and restructuring costs between $6 and $7 million.
Quick answer
ADC Therapeutics raised $100 Million in a Private Equity round, dated June 12, 2025. ADC Therapeutics is based in Lausanne, Vaud, Switzerland.
- How much did ADC Therapeutics raise?
- ADC Therapeutics raised $100 Million in a Private Equity round on June 12, 2025.
- What does ADC Therapeutics do?
- ADC Therapeutics (NYSE: ADCT) is a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs).
- Where is ADC Therapeutics based and how big is it?
- ADC Therapeutics is based in Lausanne, Vaud, Switzerland. Fundz records about 318 employees.
- Who are the decision-makers at ADC Therapeutics?
- Fundz holds 1 contact at ADC Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as ADC Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Canton Strategic Holdings, Inc. raised $1.2M (Seed) on July 25, 2025.
- Pharvaris raised $201M (Funding Round) on July 25, 2025.
- Targepeutics raised an undisclosed amount (Corporate Round) on July 24, 2025.
- DiaMedica Therapeutics raised $30M on July 23, 2025.
- Canton Strategic Holdings, Inc. raised $1.7M (Seed) on July 23, 2025.
- DiaMedica Therapeutics raised $30M (Post-IPO Equity) on July 21, 2025.
Who to call at ADC Therapeutics, and when
A new round usually means ADC Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day ADC Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ADC Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ADC Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ADC Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
ADC Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.